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Abstract
Background: Major depressive disorder is among the medical conditions with the highest negative impact on
work outcome. However, little is known regarding evidence-based interventions targeting the improvement of
work outcomes in depressed employees. In this paper, the design of a randomized controlled trial is presented in
order to evaluate the effectiveness of adjuvant occupational therapy in employees with depression. This
occupational intervention is based on an earlier intervention, which was designed and proven effective by our
research group, and is the only intervention to date that specifically targets work outcome in depressed
employees.
Methods/Design: In a two-arm randomized controlled trial, a total of 117 participants are randomized to either
‘care as usual’ or ’ care as usual’ with the addition of occupational therapy. Patients included in the study are
employees who are absent from work due to depression for at least 25% of their contract hours, and who have a
possibility of returning to their own or a new job. The occupational intervention consists of six individual sessions,
eight group sessions and a work-place visit over a 16-week period. By increasing exposure to the working
environment, and by stimulating communication between employer and employee, the occupational intervention
aims to enhance self-efficacy and the acquisition of more adaptive coping strategies. Assessments take place at
baseline, and at 6, 12, and 18-month follow-ups. Primary outcome measure is work participation (hours of
absenteeism and time until work resumption). Secondary outcome measures are work functioning,
symptomatology, health-related quality of life, and neurocognitive functioning. In addition, cost-effectiveness is
evaluated from a societal perspective. Finally, mechanisms of change (intermediate outcomes) and potential
patient-treatment matching variables are investigated.
Discussion: This study hopes to provide valuable knowledge regarding an intervention to treat depression, one of
the most common and debilitating diseases of our time. If our intervention is proven (cost-) effective, the personal,
economic, and health benefits for both patients and employers are far-reaching.
Trial registration number: NTR2057
Background
Major depressive disorder (MDD) is among the medical
conditions with the highest negative impact on work
outcome, even higher than debilitating medical condi-
tions such as rheumatoid arthritis and ischemic heart
disease [1]. Depressed employees have an increased risk
for both short-term [2-4] and long-term [5] sickness
absence, and claim substantially more work disability
pensions [6] than their non-depressed colleagues. Out of
the ten most common chronic health conditions,
depression is associated with the highest reduction in
productivity in the workplace [1,7].
Not being able to (fully) participate in the labor mar-
ket due to depression can lead to subsequent economic
and social deprivation [8]. This, in turn, can have an
added negative impact on the course of depression [9],
initiating a downward spiral. Indeed, studies have
demonstrated that employees who have experienced a
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more likely to have another mental health-related
disability episode within 12 months [3,4].
The financial burden of depression-related work dis-
ability for society is substantial, and will only continue
to increase [8]. In 2000, two-thirds of the total costs
associated with depression were work-related ($51.5 out
of a total of $83.1 billion) [10]. Even when depressed
employees are clinically treated for depression, they still
incur 3.2 times higher absenteeism-related costs when
compared to non-depressed employees [11]. Moreover,
these costs do not include costs related to productivity
loss (presenteeism) which are higher than the costs of
absenteeism and medical treatment combined [1].
Although the debilitating effects of depression on
work-ability have been consistently demonstrated, little
is known regarding evidence-based interventions target-
ing the improvement of occupational functioning in
depressed employees [12-14]. In fact, a recent review
[13] concluded that our earlier study [15] was the only
study that evaluated an intervention specifically focused
on occupational functioning in employees with depres-
sion. All other studies evaluated the effectiveness of
antidepressants and psychotherapy, aimed at symptom
reduction, with work as one of the outcome parameters.
In this review, insufficient evidence was found for the
effectiveness of standard clinical treatment on the
improvement of occupational outcomes [13]. These
findings are consistent with other studies that have
demonstrated that symptomatic improvement does not
necessarily correspond to an improvement in workplace
performance [16,17]. Instead, functional improvement
often lags behind symptom reduction [18,19]. If we
want to improve occupational outcomes in depressed
employees, we need to develop additional interventions
that target not only symptomatic, but also functional
improvement.
Based on both scientific literature [20-22] and clinical
expertise, we developed an occupational intervention
that focuses on work-participation (defined as hours of
absenteeism and time until work resumption) in
depressed employees. Results from our previous rando-
mized trial [15] evaluating this intervention (mentioned
above) were promising: The addition of occupational
therapy to standard clinical treatment resulted in a sig-
nificant reduction in sick-leave days during the first
18 months after baseline assessment. Furthermore, the
occupational intervention did not increase work stress,
was cost-effective, and was highly regarded by patients.
Unfortunately, results demonstrated that adjuvant occu-
pational therapy had no additive effect on the reduction
in depressive symptomatology.
Recently, we have developed an improved version
of our earlier occupational intervention that is shorter
(18 instead of 36 sessions) and which focuses mainly on
coping and behavioral change at the workplace. There
has also been a shift in the theoretical framework under-
lying this new occupational intervention. The earlier
intervention focused on an extensive period of pre-voca-
tional training before work resumption, an approach
that is consistent with the traditional ‘train-and-place’
model [23]. The new intervention, however, is based on
the more recent ‘place-and-train’ model [24]. Consistent
with this latter model, the patient is now encouraged to
return to the work environment as soon as possible. In
this way, the patient’s work situation is directly utilized
as an integral component of treatment. First, the return
to the work environment can serve as an ‘exposure in
vivo’ to prevent avoidance of problematic work situa-
tions. Second, the patient can immediately begin imple-
menting skills (acquired during the intervention) to
actively cope with work-related stressors. This increases
the patient’s positive feelings regarding his or her ability
to (fully) resume work. Third, by maintaining contact
with the work environment (i.e., with supervisors and
colleagues), the ‘ranks are kept open’: Increased contact
with the workplace enhances understanding and social
support from colleagues, which facilitates the employee’s
return to work. Finally, by having so called ‘work visits’,
the new intervention aims to stimulate communication
between employer and employee regarding the re-inte-
gration process. Previous findings from the physical
health field have indicated that early communication
between employer and employee lead to improved
return-to-work rates [25,26].
Although there is vast evidence that the place-and-
train approach is more effective in helping patients
return to work than the traditional train-and-place
approach [27,28], current research has solely focused on
the effect of Individual Placement and Support (IPS), a
place-and-train intervention that is specifically designed
for unemployed patients with severe mental illness (e.g.,
schizophrenia). Consequently, work goals in these stu-
dies are set lower (working for at least 1 day) than those
we seek to achieve in our study. To the best of our
knowledge, our new occupational intervention is the
first to apply the place-and-train model to improve
work-outcome in employees with depression.
In addition to the improved design of the new inter-
vention, the design of this study contains several
improvements over our earlier study [15]. First, we are
including measures of at-work productivity in addition
to measures of work participation. Second, we will
expand our sample size in order to increase power, tak-
ing into account the increased number of baseline and
outcome variables and the small to moderate effect sizes
of our earlier study. Finally, we are including personality
measures, work-place characteristics (e.g., perception of
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functioning in order to identify potential predictors of
treatment effect. Considering that clinical symptoms are
hypothesized to be associated with an underlying dysre-
gulation of cognitive processes [29], assessment of neu-
ropsychological functioning might provide a framework
for objectifying the cognitive impairments (e.g., reduced
concentration, problems with memory and planning)
that are frequently reported by patients with depression.
The objective of this paper is to present the design of
a randomized controlled trial (RCT) to evaluate the
effectiveness of adjuvant occupational therapy (OT), as
compared to care as usual (CAU: for description, see
Methods), on the work-participation of depressed
employees. We hypothesize that patients who are receiv-
ing OT have a higher average reduction in hours of
absenteeism and a faster return-to-work than patients
receiving CAU only. Second, the effectiveness of adju-
vant OT regarding work productivity, health-related
quality of life, depressive symptomatology, and neuro-
cognitive functioning is evaluated. We hypothesize that
patients receiving OT have higher work productivity
and a higher quality of life than patients receiving CAU
only. Furthermore, we hypothesize no short-term ameli-
orating effect of adjuvant OT on depressive symptoms
or neurocognitive functioning. However, over a more
prolonged interval of time, we hypothesize that patients
receiving CAU + OT will have a larger reduction in
depressive symptoms and neurocognitive functioning
than patients receiving CAU only. In addition, we aim
to evaluate the cost-effectiveness of OT from a societal
perspective. In order to identify the intervention’s
mechanisms of change (intermediate outcomes), we aim
to examine the effect of OT on work-related coping,
self-efficacy, and the patient’s perception of the work
environment. Finally, potential predictors of treatment
effect are investigated in order to adequately tailor treat-
ment in the future.
Methods/Design
Study design
Our study is a two-arm randomized controlled trial
(RCT) to evaluate the effectiveness of adjuvant occupa-
tional therapy to regular psychiatric outpatient treat-
ment in patients with depression. Patients are
randomized to ‘care as usual’ (control condition) or
‘care as usual’ with the addition of occupational therapy
(experimental condition). The study includes a baseline
assessment and follow-up assessments at 6, 12 and 18
months after start of treatment.
The trial is approved by the Medical Ethics Commit-
tee of the Academic Medical Center and the University
of Amsterdam. Patients voluntarily participate in the
study, and are offered a gift certificate of 35 euro for
participation at the last follow-up assessment. A signed
i n f o r m e dc o n s e n tf o r mi so b t a i n e df r o me a c hp a t i e n t .
Participants are informed of their right to withdraw
their participation from the study at any time, without
specification of reasons or negative consequences for
their clinical treatment.
Inclusion criteria
Participants are eligible for the study if they meet all of
the following inclusion criteria: 1) diagnosis of Major
Depressive Disorder according to DSM-IV criteria; 2) at
least 25% absenteeism due to the depressive disorder; 3)
duration of absenteeism of at least 8 weeks or the dura-
tion of the depressive disorder is at least three months;
4) aged between 18 and 65 years; 5) possibility of
returning to their own or a new job; 6) relationship
between the depressive disorder and the work situation,
i.e.; work is one of the determinants of depressive disor-
der and contributes substantially (> 25%), or depressive
symptoms reduce productivity or hinder the return to
work; 7) the participant agrees to the possibility of parti-
cipation in the occupational intervention.
Exclusion criteria
Participants are ineligible when they meet one or more
of the following criteria: 1) diagnosis of bipolar disorder,
a psychotic disorder or depression with psychotic char-
acteristics; 2) severe alcohol or drug misuse or depen-
dence; 3) severe physical problems that make
participation to the study impossible; 4) severe suicidal-
ity; 5) inpatient treatment is indicated; 6) current or
recent (i.e., during the current depressive episode) ther-
apy with a psychotherapist, psychologist, or occupational
therapist whose content resembles the content of our
occupational intervention; 7) current participation in a
research study that disables participation in our study.
Patient recruitment and procedure
Occupational physicians present potential study partici-
pants for a telephone screening, where the inclusion-
and exclusion criteria are globally assessed by an inde-
pendent psychiatrist. Next, potential eligible participants
for the study receive a standard three-hour psychiatric
intake at the outpatient department of the Mood Disor-
ders Program of the Academic Medical Center. In addi-
tion, a Structured Clinical Interview for DSM-IV
disorders [30] is administered, in order to check
whether the participant meets the DSM-IV criteria for a
diagnosis of Major Depressive Disorder and fails to
meet the DSM-IV criteria of diagnoses mentioned in
our exclusion criteria. After the psychiatric intake, eligi-
ble patients are asked to sign an informed-consent form.
Those who give written informed consent receive the
full baseline assessment.
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to the control or experimental condition. All patients
start care as usual; those randomized to the experimen-
tal condition also start occupational therapy. During
care as usual, the 6-, 12- and 18-month clinical follow-
up assessments are conducted by the treating psychiatric
resident. When participants have finished care as usual,
these assessments are conducted by an independent psy-
chiatrist. Neurocognitive assessments are conducted by a
trained researcher. During assessments, participants are
asked not to mention their intervention status in order
to preserve blinding of the researcher.
Interventions
Occupational intervention
The occupational intervention is provided by two
experienced occupational therapists, who have received
extensive training in the intervention. The intervention
consists of three phases:
Phase 1: Problem clarification
The first phase consists of an intake (one session), an
occupational anamnesis (three sessions), and a video-
observation (one session). During the intake, the
patient’s current work situation and problem areas are
explored. In addition, the patient’s treatment goals
and expectations regarding the occupational interven-
tion are examined. During the occupational ana-
mnesis, the patient’s education and occupational
history are systematically analyzed, in order to identify
recurrent ineffective coping patterns in stressful situa-
tions. During video-observation, the patient is
recorded within a simulated work environment (i.e.,
engaging in role-playing), while the patient performs
key tasks relevant to his or her job. Afterward, the
recordings are viewed, and the patient’se x p e r i e n c e s
regarding the current tasks, workload, and relation-
ships with colleagues are discussed. In this way, the
aspects of the job that the patient experiences as pro-
blematic are identified. After completing the problem
clarification phase, the occupational therapist dis-
cusses the content and goals of the intervention with
the occupational physician (OP) by telephone. The
therapist also informs the OP that patients are
required to work at least 2 hours per week when start-
ing the second phase of the intervention.
Phase 2: Occupational intervention
The second phase consists of eight group sessions and
four individual sessions. Central to this phase is the
‘Quality of Work’ (QW) model. The QW model is
based on previous literature [20-22] and consists of five
factors that affect work performance: ‘Work Load’,
‘Autonomy’, ‘Relationships at Work’‘ Job Perspective’,
and ‘Work-Home Interference’.A c c o r d i n gt ot h i s
model, whenever there is an imbalance between work
demands and work capacity, problems in occupational
functioning are likely to occur. In every group session
(approximately eight participants), the QW model is
discussed, and patients are taught how to evaluate both
the positive and negative factors in their own work
situation in accordance with the QW model. In this
way, the model provides support for breaking the work
problems down into specific, manageable pieces (as
opposed to general, insurmountable problems, as per-
ceived by patients). Based on these evaluations, each
group member decides what dimension within the
model is most important to change in his/her own
work situation. This forms the basis for their individual
work-reintegration plan. During group sessions, pro-
gress regarding each patient’s work-reintegration plan is
frequently evaluated. In addition, group sessions are
used to prepare for the meeting with the employer
(through role-playing) and to develop a prevention plan.
The advantage of discussing the QW model in a group
setting is that patients recognize they are not alone in
their problems and that they can benefit from other
participants’ feedback.
Concurrently with group sessions, three individual ses-
sions and a meeting with the employer take place. Dur-
ing individual sessions, the therapist tries to relate the
presently occurring work stressors to the patient’s recur-
rent ineffective coping-pattern (as discussed in the first
phase of the intervention). If needed, the therapist pro-
vides help with filling out the QW model. In addition,
the patient’s progress with the work-reintegration plan
is monitored during individual sessions.
During the meeting with the patient’s employer (i.e.,
supervisor), the occupational therapist educates the
employer regarding the content of the occupational
intervention and the consequences of depression for
work performance. During this meeting, the patient has
the opportunity to openly discuss work-related difficul-
ties with the employer, such as an excessive workload or
problematic interpersonal interactions.
Phase 3: Follow-up
Within four to six weeks after the completion of the
occupational intervention, patients receive a follow-up
session to discuss potential problems during the work
resumption process.
Care as usual
Care as usual consists of treatment by psychiatric resi-
dents in the outpatient clinic of the Mood Disorders
department at the Academic Medical Center according
to a treatment protocol consistent with the APA guide-
lines [31]. Visits consist of clinical management, includ-
ing psycho-education, supportive therapy, and cognitive
behavioral interventions. Therapies are supervised by an
experienced senior psychiatrist on a weekly basis. Phar-
macotherapy is started according to a protocolized
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outpatient treatment is no longer adequate, the patient
may be referred to day treatment or inpatient treatment
at the same Mood Disorders department. If the physi-
cian wishes to treat in a way that is deviating from the
care as usual protocol, he/she is required to contact the
research group.
Randomization
The randomization is conducted by an independent
research-assistant, who uses a computerized program
based on the minimization-randomization procedure
[32]. In order to assess intermediate outcomes and
potential predictors of treatment effect, two-thirds of
the participants are randomized to the experimental
condition, and one-third is randomized to the control
condition. Randomization is stratified according to
Hamilton score (≤ 17 or ≥18) and number of previous
episodes (one or two, vs. three or more).
Sample size and power
Based on previous results [15], we expect to find a dif-
ference of 25% in the main outcome variable between
the experimental group and the control group. To
achieve a power of 0.80, given a one-sided alpha of 0.05,
an estimated effect-size of 0.30, and a control-to-experi-
mental ratio of 1:2, we need at least 35 patients in the
control condition and 70 patients in the experimental
condition. Considering the high loss to follow-up in this
type of research design, we decided to expand the sam-
ple size by 10 percent. Thus, the total number of partici-
pants included in this study should be at least 116.
Power calculations are made with the program G-power
[33].
Primary outcome
Work participation
Our primary outcome measure is work participation,
defined in terms of absenteeism and work-resumption.
The first is operationalized as the average reduction in
hours of absenteeism over the three 6-month periods.
The latter is operationalized as time until full return-to
work (RTW) and time until partial RTW. Time until
full (or partial) RTW is defined as the duration of sick
leave due to depression in calendar days from the start
of treatment until full (or partial) RTW. Full RTW is
defined as working the full amount of contract hours in
own or other work for at least 4 weeks, without partial
or full recurrence. Partial RTW is defined as working an
increment of at least 5 hours (when compared to the
hours worked at baseline), for at least 4 weeks without
partial or full recurrence. Data are derived from diaries
that patients keep on a weekly basis during the 18-
month study period.
Secondary outcomes
Work productivity
Work productivity is assessed in two ways. First, partici-
pants are asked to record weekly their efficiency for the
hours worked, on a scale of 1 (’not productive at all’)t o
10 (’very productive’). Second, the 25-item Work Limita-
tions Questionnaire [34,35] is used to assess productivity
loss (presenteeism). The WLQ has demonstrated good
reliability (all scales have alpha’s above 0.90) and con-
struct validity in both patient and employee populations
[35]. In addition to the WLQ total score, we are exam-
ining three subscales (the ‘Output’, ‘Time’,a n d‘Mental-
Interpersonal’ subscale) individually, since previous
results have demonstrated a strong association between
these subscales and depression-related work limitations
[16,36].
Depressive symptomatology
Severity of depression is measured with the Hamilton
Rating Scale for Depression (HRSD) and the Inventory
of Depressive Symptoms (IDS-SR). The 17-item HRSD
[37] is a semi-structured clinical interview that covers a
range of affective, behavioral and biological symptoms.
Scores on this clinician-rated instrument range from 0
to 56, where a score of ≥ 23 is qualified as ‘very severe’,
19-22 is qualified as ‘severe’, 14-18 as ‘moderate’,8 - 1 3
as ‘mild’,a n d≤ 7a s‘normal’ [38,39]. The HRSD has
acceptable psychometric properties [40]. The IDS-SR
[41,42] is a 30-item self-rated instrument to measure
the severity of depression, with scores ranging from 0 to
84. A score of ≥ 39 is qualified as ‘severe’,3 0 - 3 8a s
‘moderate to severe’, 22-30 as ‘moderate’, 14-22 as ‘mild’
and ≤ 13 as ‘normal’ [41]. The IDS-SR has good reliabil-
ity and validity [42,43].
Health-related quality of life
Health-related quality of life is measured with the MOS-
SF 36 (Medical Outcomes Study-Short Form), a
validated and widely used instrument for the assessment
of health status [44,45]. This self-report questionnaire
contains 36 items regarding behavioral functioning and
perceived psychological well-being during the previous
four weeks. Responses to the 36 items can be aggregated
into eight scale scores. Each scale score can be
converted into a 0 to 100 scale, with higher scores
indicating higher levels of functioning. The Dutch trans-
lation of the MOS-SF 36 has demonstrated adequate
psychometric properties [46].
Neurocognitive functioning
Speed of information processing is measured with the
Trailmaking Test [47,48] part A and the Stroop Color-
Word Test [49] part I. Selective attention is measured
with the Stroop Color-Word Test Part III, corrected for
part II. Divided attention is measured by Trailmaking
Test part B, corrected for part A. Working memory is
assessed by the subtest ‘Letter-Number sequencing’ of
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the manual version of the Tower of London [51].
Economic evaluation
Medical consumption is assessed with the Tic-P (Trim-
bos/iMTA questionnaire for Costs associated with Psy-
chiatric Illness) [52]. The Tic-P is a validated Dutch
questionnaire that is commonly used in economic eva-
luations of treatment in mental-health treatment. In
order to calculate the indirect costs of both absenteeism
and productivity loss, we are using data from the Work
Limitations Questionnaire and weekly self-report diaries
(self-constructed).
Intermediate outcomes: Mechanisms of change
Work-related coping
One of the central goals in occupational therapy is to
teach patients how to actively cope with the problems
they encounter work-related situations. Coping behavior
is measured by the Utrecht Coping List (UCL) [53],
adapted to specifically address coping behavior in work-
related situations. For our study, we are including the
UCL-subscales ‘Avoidance behavior’ (avoiding proble-
matic situations, 8 items), ‘Passive reaction’ (feeling
unable to do anything about the situation, being
absorbed by problems, 7 items) and ‘Active problem
focusing’ (approaching problems with confidence and in
a goal-directed way, 7 items). All items are rated on a 4-
point scale, ranging from ‘seldom or never’ (coded 0) to
‘very frequently’ (coded 4).
Self-efficacy
In our occupational intervention, an important mechan-
ism of change is to provide patients with more perceived
control over their work situation. In other words, our
occupational intervention aims to enhance patients’
belief in their capacity to deal with work demands, or
self-efficacy. Work-related self-efficacy is measured by
the 11-item questionnaire ‘Expectations regarding work
resumption’ [54].
Perception of the work environment
The ‘Perception and Judgment of the Working situation’
questionnaire (VBBA) measures the patients’ perception
of the working situation. The following VBBA subscales
are evaluated in order to longitudinally assess changes
in perception of the work environment: Work satisfac-
tion, work tempo, work load (mental and emotional),
relationships at work (with colleagues and supervisors),
and work involvement.
Potential predictors of treatment effect
To investigate potential predictors of treatment effect, a
wide range of variables are included in this study. At
baseline, the following variables are measured: Socio-
demographic characteristics (e.g., age, education level,
gender), clinical history (e.g., severity of depression,
number of previous episodes), personality (e.g., neuroti-
cism, extraversion), job characteristics (e.g., type of pro-
fession, years of work experience, number of contract
hours, contract type) and a retrospective assessment of
psychosocial work characteristics four weeks prior to
sick leave (e.g., work load, variation in tasks, relationship
with supervisor/colleagues). In addition, several aspects
within the neurocognitive domain are assessed at base-
line as potential predictors of treatment effect: Speed of
processing is measured with the Trailmaking Test
[47,48] part A and the Stroop Color-Word Test [49]
part I. Selective attention is measured with the Stroop
Color-Word Test part III, corrected for part II. Divided
attention is measured by the Trailmaking Test part B,
corrected for part A. Working memory is assessed by
the subtest ‘Letter-Number sequencing’ of the WAIS-III
[50]. Executive functioning is assessed by the manual
version of the Tower of London [51].
Statistical analysis
Data are analyzed according to the intention-to-treat prin-
ciple, i.e., based on original intervention assignment, irre-
spective of the actual treatments received. Independent
samples t-tests and c²-tests are used to evaluate potential
differences in baseline characteristics between the interven-
tion and control condition. In case of significant baseline
differences between groups, the propensity score method
[55,56] is used to adjust for these variables in the evalua-
tions of the treatment effect. Missing independent variables
are imputed using multiple imputation techniques.
Effect of the intervention
To take into account potential biased outcomes caused
by selective loss to follow-up, we use a generalized lin-
ear mixed model (GLMM) analysis approach, which,
assuming missing at random (MAR) for missing values,
gives unbiased effect estimates. MAR is a less restrictive
assumption than missing completely at random, and
allows loss to follow-up to be related to baseline charac-
teristics that are incorporated in the regression model.
GLMM comprises, among others, logistic regression
analysis (dichotomous outcomes; e.g., proportion of par-
ticipants who have returned to work), Poisson regression
(count outcomes; e.g., hours worked), Cox regression for
censored data (e.g., time to full and partial return to
work), and linear regression (continuous outcomes; e.g.,
scores on depression scales). In all of these analyses,
intervention is the independent variable, and a propen-
sity score [55,56] is entered as a covariate to adjust for
potential confounders. Since work-productivity and per-
ception of the work environment are conditional upon
whether participants have returned to work, a pattern-
mixture model analysis is applied for the analysis of
these data [57,58].
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Predictors are assessed in two ways. First, predictors
(e.g., Y) are assessed through the statistical significance
of the intervention by Y interaction term. Second, pre-
dictors are assessed by using these variables instead of
the intervention variable in the mixed model regression
analysis restricted to the subgroup that was allocated to
the occupational intervention condition.
Cost-effectiveness
Cost-effectiveness is assessed from a societal perspective.
Therefore, both the direct costs (due to use of mental-
health care) and indirect costs (due to production losses
and absenteeism) during the 1.5-year follow-up are
included. Both direct and indirect costs are estimated
according to the Dutch guidelines for cost-analysis in
health-care research [59]. The indirect costs are calcu-
lated by using the Friction Cost Method [60].
Discussion
This paper describes the design of a randomized con-
trolled trial to evaluate the effectiveness of adjuvant
occupational therapy, as compared to care as usual, on
the work-participation of depressed employees. Consid-
ering that depression is among the top three disorders
with the highest negative impact on work functioning,
t h el a c ko fi n t e r v e n t i o n st a rgeting the improvement of
occupational functioning is noteworthy. Only one pre-
vious study [15], also conducted by our research group,
has evaluated the effectiveness of an occupational inter-
vention in depressed employees. On the basis of this
earlier intervention, we have developed an improved
new intervention that focuses on an early return to the
work environment and the acquisition of more adaptive
coping strategies.
An important strength of our study is the wide range
of outcome measures that will be used to evaluate the
effectiveness of adjuvant occupational therapy. Few stu-
dies have included outcome measures on both the level
of work-participation and work-functioning; even fewer
studies have included potential predictors of treatment
effect. To our knowledge, this is the first study to
include measures to explore potential working mechan-
isms of treatment in this field. This assessment enables
us to evaluate a comprehensive picture of the effect of
adjuvant occupational therapy in depressed employees.
A second strength of the present study is the extensive
follow-up period. In their article on improving return-
to-work (RTW) research, Pransky and colleagues [61]
recommended that “research on RTW requires multiple
longitudinal observations in order to fully understand
the implications of the effect of an intervention targeting
RTW” (p.456).
A possible limitation of our study is the lack of a wait-
ing-list control condition. Thus, in the current study we
are unable to compare our findings to a potential
improvement in work functioning that might occur dur-
ing the natural course of depression (i.e., spontaneous
recovery). On the other hand, it is considered unethical
to deprive patients of evidence-based effective treatment,
especially over the course of an 18-month period. Pre-
vious studies have demonstrated that chances for relapse
increase in untreated depression [62,63]. Another possi-
ble limitation of this study is the use of self-report mea-
sures for sickness absence data, which may be
susceptible to recall bias. In order to minimize bias,
patients are asked to record the number of hours
worked on a weekly basis. Previous findings have
demonstrated that - when reported on a frequent basis -
employee records correspond highly with employer
records of absenteeism [64].
To conclude, this study hopes to provide valuable
knowledge regarding an occupational intervention for
treating one of the most common and debilitating dis-
eases of our time. If our intervention is proven (cost-)
effective, the personal and economic benefits for both
patients and employers are far-reaching.
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